Rewiring the Chronic Pain Experience: Single-Session Model of Pain Reprocessing Therapy (PRT) at The Ottawa Hospital
Rewiring the Chronic Pain Experience: Feasibility and Pilot Testing of a Single-Session, 4-Hour Delivery Model of Pain Reprocessing Therapy (PRT) at The Ottawa Hospital (TOH)
The goal of this study is to find out if a one-time session of Pain Reprocessing Therapy (PRT) intervention improves participant's mood and pain. Participants in this 4 hours session will be 40 patients who've been referred to the The Ottawa Hospital Pain Clinic (TOHPC) for chronic pain.
The main questions of this study are:
- Can we recruit 40 participants within 6 months?
- Do at least 32 participants complete the session and answer follow up questions?
- Does 1 session of PRT have a positive impact on participants' mood and pain?
Participants in this study will:
- Attend 1 session of PRT.
- Answer questions that relate to their experience of pain and their mood. They will answer these questions immediately before/after the session, 1 week after the session, and 1 month after the session.
- After the session, some participants will participate in an interview to talk about their experience.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Susan Ward, MSW
- Telefonnummer: 72123 613-737-8899
- E-post: SWard@toh.ca
Studer Kontakt Backup
- Navn: Research Co-ordinator
- Telefonnummer: 73903 6137378899
- E-post: painresearch@toh.ca
Studiesteder
-
-
Ontario
-
Ottawa, Ontario, Canada, K1H8L6
- Rekruttering
- The Ottawa Hospital
-
Hovedetterforsker:
- Susan Ward, MSW
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
-
Minimum age of 18 years or older at time of consent.
-
Chronic pain persisting for a minimum of 3 months, consistent with the International Association for the Study of Pain (IASP) definition of chronic pain.
-
Self-reported 1-week average pain intensity score between 4/10 and 9/10 on the Brief Pain Inventory (BPI)12 at screening.
o Note: Individuals scoring less than 4/10 or more than 9/10 will be directed to other pain clinic workshops and available resources (e.g., Power Over Pain)
-
Referred to TOHPC and triaged by a registered nurse, nurse practitioner, or physician to the "diffuse pain" pathway;
-
Completed the initial pain clinic patient education and resource session (PERS) for patients triaged to the "diffuse pain" pathway;
-
Currently waiting for a 1st consultation with the Nurse Practitioner assigned to the "diffuse pain" pathway.
-
Able to read, write, and communicate in English at a level sufficient to engage with research team, the psychoeducational content, and to complete self-report measures.
-
Able to attend a single, in-person 4-hour group session at TOHPC in Ottawa on a scheduled weekday.
Exclusion Criteria:
- Active mental health symptoms that significantly interfere with the ability to engage with psychoeducational content (e.g., dissociation, active psychosis), or participate in a group setting
- Cognitive impairment that significantly limits the ability to comprehend study information, provide informed consent, or meaningfully engage with psychoeducational content.
- Scheduled for a major surgical procedure within the study timeframe.
- Currently receiving other individual or group psychotherapy that directly targets pain, pain cognitions, or pain-related emotional responses within the 12 weeks prior to enrollment.
- Currently receiving interventional pain management services (e.g., injections, nerve blocks) from another clinic or institution within the 12-week period prior to enrollment through the 3-month follow-up.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Pain Reprocessing Therapy (PRT) session
|
The intervention involves a single 4-hour PRT in-person group session (up to 20 patients per group) at The Ottawa Hospital Pain Clinic, delivered by a PRT certified clinician. The intervention is a brief mindfulness exercise (mindfulness of breath, energy, emotions, thoughts, sensations), followed by 90 minutes of didactic content focused on pain science education and foundation of pain reprocessing therapy. This includes interactive discussions, self-reflection, and skills building. This is followed by a brief exercise called predictive coding where participants are invited to draw a picture representing their pain. The remainder of the session includes gentle movement, somatic tracking, and practices to increase positive affect induction- specifically leaning into positive or neutral sensations and establishing short-term safety behaviours. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Clinical Effectiveness: Brief Pain Inventory (BPI) Pain Intensity and Pain Interference
Tidsramme: Baseline, 1 week post-intervention, 1 month follow up.
|
Clinical effectiveness outcome measurement tools include Brief Pain Inventory (BPI): Participants will localize their pain through a drop down menu, in which they will select the applicable body part(s) where they experience pain. The BPI Pain Intensity and Pain Interference scales will then be administered. The pain intensity subscale includes 4 pain intensity ratings using an 11-point numerical rating scale (0-10) on current pain, average pain, worst pain during the last 7 days and least pain during the last 24 hours. The pain interference subscale includes 7 interference items that ask the patient to respond using an 11-point numerical rating scale (0-10). These items include the effect on general activity, mood, walking ability, normal work (including housework), relations with other people, sleep, and enjoyment of life. |
Baseline, 1 week post-intervention, 1 month follow up.
|
|
Interview
Tidsramme: Interviews will be conducted within 6 months of participating in the PRT session.
|
A random selection of participants will be interviewed regarding their PRT experience. |
Interviews will be conducted within 6 months of participating in the PRT session.
|
|
Clinical Effectiveness: Pain Self-Efficacy Questionnaire (PSEQ-10)
Tidsramme: Baseline, 1 week post-intervention, 1 month follow up.
|
Clinical effectiveness outcome measurement tools include Pain Self-Efficacy Questionnaire (PSEQ-10): The PSEQ-10 is a validated 10-item tool for assessing the patient's pain self-efficacy or belief in one's capability to perform activities even when undergoing pain. The 10 items ask the patient to rate their confidence in doing activities on a 7-point numerical rating scale (0-6), with higher scores indicating greater confidence. |
Baseline, 1 week post-intervention, 1 month follow up.
|
|
Clinical Effectiveness: Patients' Global Impression of Change (PGI-C) Scale
Tidsramme: 1 week post-intervention, 1 month follow up.
|
Clinical effectiveness outcome measurement tools include Patients' Global Impression of Change (PGI-C) Scale: The PGI-C is a validated single- item self-report measure used to assess a patient's perceived change in overall status following a treatment or intervention. Patients select one of 7 options to describe their experience, ranging from "very much worse" to "very much improved." The PGI-C is widely used in chronic pain research and has demonstrated sensitivity to clinically meaningful change across a range of pain populations. |
1 week post-intervention, 1 month follow up.
|
|
Clinical Effectiveness: Positive and Negative Affect Scale (PANAS)
Tidsramme: Day of Intervention, 1 week post-intervention, 1 month follow up.
|
Clinical effectiveness outcome measurement tools include Positive and Negative Affect Scale (PANAS) PANAS is a validated 20-item self-report measure assessing two distinct dimensions of mood: positive affect and negative affect. Participants rate the extent to which they have experienced each emotion using a 5-point Likert scale (1 = very slightly or not at all, 5 = extremely), with higher positive affect scores and lower negative affect scores reflecting better emotional well-being. The PANAS has demonstrated strong reliability and validity across clinical populations, including individuals with chronic pain. |
Day of Intervention, 1 week post-intervention, 1 month follow up.
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility of recruitment
Tidsramme: Baseline
|
• Rates of participant eligibility and consenting will be tracked o The single session PRT model will be considered feasible if we can recruit our target sample size of 40 participants over a 6-month period. |
Baseline
|
|
Rate of participant accrual/completion
Tidsramme: Baseline, Day 7, and Day 30
|
• Rates of participant accrual, screening, and 1-week and 1-month assessment completion will be tracked o The evaluation procedures will be considered feasible if we retain more than 80% of participants at 1-month follow-up. |
Baseline, Day 7, and Day 30
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Susan Ward, MSW, The Ottawa Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- 7131-20260398-01H
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .